VivoSim Labs Inc. (VIVS)
VIVS trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1742
+0.12% on the day
Market cap
$2.9M
Nano cap
Revenue · 2025
$131K
-9.0% on 2024
Net income · 2025
-$13.8M
-10567.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | VIVS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001497253 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $131K |
| Net income | -$13.8M |
| Operating income | -$11.5M |
| Net margin | -10567.2% |
| Operating margin | -8768.7% |
| Revenue growth | -9.0% |
| Cash | $4.3M |
| Total assets | $7.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 22.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1 | 2026-07-31 |
| Latest annual report | 10-K | 2026-07-14 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-10-06 |
| Latest proxy | DEF 14A | 2026-08-21 |
Source: SEC EDGAR submissions feed, 818 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | $0.1760 | -1.24% | $2.5M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| HLSQ | Tessera Defense and Homeland Security Inc. | $0.2600 | -7.08% | $2.3M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.23 | +6.03% | $1.7M |
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
| CELZ | Creative Medical Technology Holdings Inc. | $0.8199 | -2.51% | $6.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier